Biotech Investors & VC Firms in Europe
204 firms in this list, with a median first check of $540K. 19 of them lead rounds. Generated from verified public data and updated continuously.
Omega Funds
BostonSeed–Late Stage
11 people
Avant Bio
New YorkSeed–Growth
5 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
11 people
European Circular Bioeconomy Fund
BonnGrowth–Late Stage$2.7M – $10.8M
11 people
Frazier Healthcare Partners
SeattleGrowth$50M – $400M
11 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $32.4M
11 people
Hercules Capital, Inc.
San MateoSeed–Late Stage$500K – $50M
11 people
Impact Fund Denmark
Copenhagen KSeed–Late Stage$2.2M – $70.2M
11 people
JJDC
New BrunswickSeed–Series B$500K – $5M
11 people
Korys
HalleGrowth$5.4M
11 people
MCI Capital S.A.
WarsawGrowth$27M – $108M
11 people
MVM Life Science Partners
BostonSeed–Late Stage$3.8M
11 people
PAI Partners
Paris$108M – $324M
11 people
PortfoLion Capital Partners
BudapestSeed–Late Stage$540K – $32.4M
11 people
Talde Private Equity
BilbaoGrowth$5.4M – $16.2M
11 people
Roche Venture Fund
BaselSeries A$648K – $3.2M
2 people
Bioqube Ventures
BrusselsSeed–Late Stage$108K – $6.5M
9 people
Brightlands Venture Partners
GeleenSeed–Series B$540K – $2.2M
9 people
Day One Capital
BudapestSeed–Series A$324K – $1.6M
9 people
dsm-firmenich Venturing
MaastrichtPre-Seed–Late Stage$108K – $5.4M
9 people
Enterprise Investors Sp. z o. o.
WarsawSeries A–Series B$21.6M – $81M
9 people
PM Equity Partner
LausanneSeries A–Series B$2M – $50M
9 people
Selvedge Venture
Pre-Seed–Series A
3 people
Taiwania Capital
Santa ClaraSeed–Series A
11 people
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.